BioRestorative Therapies Inc. Registered Shares DL -,01
- BID
0.276
- ASK
0.29
- 1,000 Units900 Units
- 07/21, 09:33:32 AM
Sector and Industry
Consumer Non-Cyclicals, Household Products
Performance (1Y)
78.79%
Market Cap
12.51 Mil.
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-1.40 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Procter & Gamble Co | 317.85 Bil. | 77.53 Bil. | 24.48 | +6.80 % | 0.00 | - |
| L'Oreal S.A. | 195.68 Bil. | 44.05 Bil. | 31.93 | -4.39 % | 0.00 | - |
| Unilever PLC | 121.38 Bil. | 50.55 Bil. | 20.33 | -1.01 % | 0.00 | - |
| Midea Group Co. Ltd. 'H' | 70.60 Bil. | 56.38 Bil. | 13.51 | +9.42 % | 0.00 | - |
| Colgate-Palmolive Co | 53.91 Bil. | 18.07 Bil. | 30.06 | -29.24 % | 0.00 | - |
| Reckitt Benckiser Group PLC | 46.22 Bil. | 16.60 Bil. | 12.82 | +121.23 % | 0.00 | - |
| Kimberly-Clark Corp | 28.51 Bil. | 14.58 Bil. | 16.63 | -38.93 % | 0.00 | - |
| Kenvue Inc. | 28.05 Bil. | 13.41 Bil. | 22.50 | +36.84 % | 0.00 | - |
| Estee Lauder Companies Inc | 24.76 Bil. | 13.14 Bil. | - | -389.00 % | 0.00 | - |
| Beiersdorf AG | 20.47 Bil. | 9.85 Bil. | 22.05 | +2.96 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.276 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:33:32 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.276 | 0.272 |
| PREV. DAY'S PRICE | 0.28 | (07/20) |
| CHANGE DAY BEFORE | -0.00 | -1.43 % |
| 52 WEEK HIGH / LOW | 1.59 (09/01) | 0.127 (05/20) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -2.28 | -1.07 | -1.40 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 0.82 | 1.16 | 30.42 | - | - |
PRICE - SALES RATIO | 50.34 | 27.69 | 29.38 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A3C9XF |
| ISIN | US0906556065 |
| SYMBOL | 9OF |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | BIORESTORAT.THERAP.DL-,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Consumer Non-Cyclicals, Household Products |
| NUMBER OF SHARES | 6.77 Mil. |
| MARKET CAPITALISATION | 12.51 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -4.76 % | -18.13 % | 32.08 % | -70.21 % | -78.79 % | -89.63 % | - | -68.18 % |
| HIGH | 0.30 | 0.37 | 0.51 | 0.98 | 1.59 | 3.32 | - | 1.04 |
| LOW | 0.28 | 0.28 | 0.13 | 0.13 | 0.13 | 0.13 | - | 0.13 |
Dividende
pro Aktie
BIORESTORAT.THERAP.DL-,01 does not deliver dividend information
Company profile
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.